ELECTROPORATION ENHANCES C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDE EFFICACY

被引:104
作者
BERGAN, R
CONNELL, Y
FAHMY, B
NECKERS, L
机构
[1] Clinical Pharmacology Branch, NCI, NIH, Bethesda
关键词
D O I
10.1093/nar/21.15.3567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obtaining high transfection efficiencies and achieving appropriate intracellular concentrations and localization are two of the most important barriers to the implementation of gene targeted therapy. The efficiency of endogenous uptake of oligodeoxynucleotides (ODNs) varies from cell type to cell type and may be a limiting factor of antisense efficacy. The use of electroporation to obtain high intracellular concentrations of a synthetic ODN in essentially 100% of viable cells is described. It is also shown that the transfected ODNs initially localize to the nucleus and remain there for at least 48 hours. The cellular trafficking of electroporated ODNs is shown to be an energy dependent process. Targeting of the c-myc proto-oncogene of U937 cells by electroporation of phosphorothloate-modified ODNs results in rapid and specific suppression of this gene at ODN concentrations much lower than would otherwise be required. This technique appears to be applicable to a variety of cell types and may represent a powerful new investigative tool as well as a promising approach to the ex vivo treatment of hematologic disorders.
引用
收藏
页码:3567 / 3573
页数:7
相关论文
共 31 条
[1]   INTERACTIONS OF ANTISENSE DNA OLIGONUCLEOTIDE ANALOGS WITH PHOSPHOLIPID-MEMBRANES (LIPOSOMES) [J].
AKHTAR, S ;
BASU, S ;
WICKSTROM, E ;
JULIANO, RL .
NUCLEIC ACIDS RESEARCH, 1991, 19 (20) :5551-5559
[2]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[3]  
Chang DC, 1992, GUIDE ELECTROPORATIO
[4]  
CHIN D J, 1990, New Biologist, V2, P1091
[5]   PURIFICATION AND CHARACTERIZATION OF A MAMMALIAN ENDOEXONUCLEASE [J].
COUTURE, C ;
CHOW, TYK .
NUCLEIC ACIDS RESEARCH, 1992, 20 (16) :4355-4361
[6]   ADENOVIRUS ENHANCEMENT OF TRANSFERRIN POLYLYSINE-MEDIATED GENE DELIVERY [J].
CURIEL, DT ;
AGARWAL, S ;
WAGNER, E ;
COTTEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8850-8854
[7]   ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT [J].
EVAN, GI ;
LEWIS, GK ;
RAMSAY, G ;
BISHOP, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3610-3616
[8]  
GAO WY, 1993, MOL PHARMACOL, V43, P45
[9]  
Geselowitz D A, 1992, Antisense Res Dev, V2, P17
[10]  
HARELBELLAN A, 1988, J IMMUNOL, V140, P2431